"Even when individuals share the same BMI, their underlying body composition and even hormonal profiles can differ significantly, with coffee consumption emerging as a potential distinguishing factor."
A recent study published in the European Journal of Nutrition has shed light on the complex relationship between coffee intake and an individual’s body composition and hormonal balance. While Body Mass Index (BMI) is a widely used metric for assessing weight relative to height, this research highlights its limitations in capturing the full picture of an individual’s health. The findings suggest that even individuals with identical BMI, height, and weight can harbor markedly different body compositions, with coffee consumption playing a notable role. This exploratory study, conducted on participants of the Northern Finland Birth Cohort 1966, opens new avenues for understanding how habitual coffee drinking might influence metabolic health and sex hormones, particularly in middle-aged adults.
The research, conducted by scientists at the University of Oulu, analyzed data from 2,264 adults who were measured at age 46 during a 2012 follow-up. The study meticulously examined various markers of body composition, including body fat percentage, total fat mass, visceral fat (the metabolically active fat stored deep within the abdomen), and skeletal muscle mass. Participants were categorized into four groups based on their self-reported daily coffee intake: none, one to two cups, three to four cups, and five or more cups. Notably, individuals who reported the highest coffee consumption exhibited distinct physiological characteristics compared to those who drank less. These heavy coffee drinkers tended to have lower body fat percentages, reduced total fat mass, and less visceral fat. Conversely, they possessed a greater proportion of skeletal muscle mass. These differences in body composition were observed even when crude measures of size, such as BMI, waist circumference, hip circumference, and waist-to-hip ratio, were comparable across the groups, underscoring the inadequacy of BMI as a sole indicator of health.
The statistical analysis revealed significant correlations between coffee intake and several key health markers. Body fat percentage showed a clear inverse relationship with coffee consumption, decreasing significantly as intake increased, with a p-value below .001. Similarly, total fat mass and visceral fat area, a crucial indicator of metabolic risk, also decreased with higher coffee consumption (p-values of .002 and .048, respectively). In contrast, skeletal muscle mass exhibited a positive correlation with coffee intake, increasing significantly as consumption rose (p-value below .001). These patterns remained consistent even after the researchers adjusted for extreme BMI values, reinforcing the robustness of the findings.
Beyond body composition, the study also explored the link between coffee consumption and metabolic markers. Coffee intake was found to be inversely correlated with circulating levels of branched-chain amino acids (BCAAs) in both men and women. Chronically elevated levels of BCAAs have been previously associated with insulin resistance and an increased risk of developing type 2 diabetes, often years before clinical diagnosis. The researchers consider this a potentially novel finding, suggesting a specific role for coffee in influencing these metabolic pathways.
The hormonal analysis yielded particularly intriguing, and somewhat counterintuitive, results, primarily observed in men, who constituted 47% of the study sample. In fully adjusted models, each additional daily cup of coffee was associated with an increase in total testosterone and bioavailable testosterone. Simultaneously, it was linked to higher levels of sex hormone-binding globulin (SHBG), a protein that binds to sex hormones. However, paradoxically, coffee consumption also correlated with lower levels of free testosterone and a reduced free androgen index. This complex interplay, where total hormone levels rise while the unbound, biologically active fraction decreases, can be explained by the concurrent increase in SHBG. The authors reference a large analysis of U.S. men which indicated that low total testosterone and low SHBG were independently linked to metabolic syndrome, while free and bioavailable testosterone were not. From this perspective, the hormonal profile observed in higher coffee drinkers might be considered metabolically favorable.
In women, the hormonal findings were less pronounced but showed a similar pattern. They exhibited higher SHBG levels and lower free testosterone and free androgen index, with no significant association noted for total or bioavailable testosterone. Women diagnosed with polycystic ovary syndrome (PCOS) or those with missing data were excluded from these specific analyses to maintain the integrity of the hormonal assessments. Luca Verroest, a doctoral researcher at the University of Oulu and the study’s lead author, emphasized the broad implications of these findings, stating, "Coffee is consumed by millions of people every day, yet we still know surprisingly little about how it relates to our metabolism and hormones."
Despite the compelling associations, the researchers caution against drawing definitive causal conclusions due to several limitations inherent in the study’s design. Firstly, the cross-sectional nature of the study means that coffee habits and body composition were measured at a single point in time. This prevents the establishment of a cause-and-effect relationship; it is equally plausible that leaner individuals with better metabolic health are simply more inclined to consume more coffee. This is known as reverse causation.
Secondly, the assessment of body composition relied on bioelectrical impedance analysis (BIA) rather than more precise methods like DXA (dual-energy X-ray absorptiometry) or medical imaging. BIA estimates are based on assumptions regarding body water content and tissue conductivity, and the authors acknowledge that the visceral fat measurement, in particular, is a derived estimate.
Thirdly, the self-reported nature of coffee intake, gathered through a single postal questionnaire, introduces potential inaccuracies. The questionnaire did not define a standard cup size, nor did it collect data on bean type, roast level, grind, or the addition of milk or sugar. While nearly all participants reported consuming filtered coffee, which is known to remove diterpenes that can elevate LDL cholesterol, this variability in preparation methods could influence outcomes.
Furthermore, the observed correlations, while statistically significant, were generally small in magnitude. Correlations for metabolites were typically under 0.15, and for cardiometabolic markers, under 0.2. Testosterone levels also exhibit considerable natural fluctuation within individuals over time, and in this study, it was measured only once. The authors explicitly state that these findings represent population-level patterns rather than individual-level changes that one might detect in personal bloodwork. It’s also worth noting that higher coffee consumers in this cohort were more likely to smoke and less likely to hold a university degree, although the regression models did account for these factors.
To definitively establish causality and identify the specific bioactive compounds within coffee responsible for these observed effects, further research is imperative. The Oulu team plans to investigate whether coffee itself is the driving factor and to pinpoint which of coffee’s approximately one thousand bioactive compounds might be implicated. Caffeine is a primary suspect, and prior genetic analyses have indeed linked higher predicted plasma caffeine levels to lower fat mass. However, a separate trial in trained athletes found that decaffeinated coffee also increased post-exercise testosterone, suggesting that other compounds, such as chlorogenic acids or trigonelline, might also play a role.
The researchers are currently conducting studies in animal models and aim to progress to human intervention trials. Until such studies provide conclusive evidence, the current findings do not support an increase in coffee consumption for the purpose of altering body composition. Existing federal guidelines on caffeine intake remain in place. The U.S. Food and Drug Administration (FDA) generally considers up to 400 milligrams of caffeine per day, equivalent to about four to five cups of coffee, to be safe for most healthy adults, not typically associated with negative effects. Individuals who are pregnant, have heart rhythm disorders, or are taking medications that interact with caffeine should consult with a healthcare professional for personalized advice.
Key Questions Answered
What did the study actually measure?
The study measured coffee intake via questionnaire, body composition using bioelectrical impedance, and various blood markers including metabolites, glucose, insulin, and sex hormones, all assessed at a single visit when participants were 46 years old.
Does this mean coffee burns visceral fat?
No. The study’s design is cross-sectional, meaning it cannot establish a cause-and-effect relationship. It is possible that leaner, more metabolically healthy individuals simply tend to drink more coffee.
Why did total testosterone rise while free testosterone fell?
This phenomenon is attributed to a concurrent rise in sex hormone-binding globulin (SHBG). As SHBG levels increased, more testosterone became bound to this protein, leaving a smaller, unbound fraction (free testosterone).
Do the findings apply to women?
The findings have partial applicability to women. They exhibited increased SHBG and decreased free testosterone and free androgen index, but no significant association was found with total or bioavailable testosterone levels.
How much coffee is considered safe?
The FDA suggests that up to 400 milligrams of caffeine daily, approximately four to five cups of coffee, is generally not associated with negative effects in healthy adults. However, individual tolerance can vary significantly.
Should anyone change their coffee habit based on this?
No. The researchers emphasize that longitudinal and intervention studies are necessary to confirm these findings and establish causality before any dietary recommendations can be made based on this research.
